celltrion vegzelma permission canada

Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...

South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...

South Korea’s construction company DL E&C Co. is set to make inroads into the small modular reactor (SMR) business for future growth ...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

LG Magna e-Powertrain Co. will invest $78 million in its Chinese plant of electric vehicle parts to meet growing demand in the world’s largest...

Hyundai Engineering Co., the plant engineering and construction unit of South Korea’s Hyundai Motor Group, and Ultra Safe Nuclear Corp. (USNC)...

Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...

South Korea’s POSCO Chemical Co. and General Motors Co. on Friday agreed to set up a joint venture that will supply about 20 trillion won ($16...

South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...

The world’s second-largest battery maker LG Energy Solution Ltd. and multinational automaker Stellantis N.V. have agreed to build a $4.1 billi...

South Korea's Lotte Confectionery Co. has invested around 10 billion won ($8 million) in Canada’s edible insect protein producer Aspire Food G...

South Korea’s POSCO Chemical Co. and US top automaker General Motors Co. decided to build a battery material plant in Canada.POSCO Chemical an...

South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...

EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...

Paris Baguette, South Korea’s top bakery franchise, has successfully settled in the US market, paving the way to expand its business throughou...

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

South Korea's Hankook Tire Group has acquired a majority stake worth 204.5 billion won ($173 million) in Canada's Preciseley Microtechnology Corp., ...

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...

South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...

South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...

South Korea’s biopharmaceutical company Samsung Bioepis Co. won approval from European authorities for sale of Byooviz, its ophthalmology bios...

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...

The Canada Pension Plan Investment Board (CPPIB) has named Suyi Kim, its Asia head, as the global chief of its private equity business, effective Se...

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...

South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...